We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RLAY icon
2151
Relay Therapeutics
RLAY
$4.36B
$74K ﹤0.01%
4,490
-5,916
-57% -$106K
RVMD icon
2152
Revolution Medicines
RVMD
$43.3B
$74K ﹤0.01%
3,418
+1,481
+76% +$36.5K
RXT icon
2153
Rackspace Technology
RXT
$1.11B
$74K ﹤0.01%
39,197
+36,632
+1,428% +$94.2K
SPT icon
2154
Sprout Social
SPT
$596M
$74K ﹤0.01%
1,208
-3,379
-74% -$207K
URBN icon
2155
Urban Outfitters
URBN
$6.52B
$74K ﹤0.01%
2,639
+447
+20% +$12K
VRRM icon
2156
Verra Mobility
VRRM
$723M
$74K ﹤0.01%
4,349
+3,266
+302% +$52.2K
VRTS icon
2157
Virtus Investment Partners
VRTS
$1.14B
$74K ﹤0.01%
387
+322
+495% +$65.1K
OMGA
2158
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$74K ﹤0.01%
12,163
+8,211
+208% +$57.2K
AIP icon
2159
Arteris
AIP
$1.38B
$73K ﹤0.01%
17,463
+15,275
+698% +$79.9K
ARCB icon
2160
ArcBest
ARCB
$3.3B
$73K ﹤0.01%
796
+751
+1,669% +$67.5K
CENX icon
2161
Century Aluminum
CENX
$4.68B
$73K ﹤0.01%
7,324
+5,888
+410% +$61K
ERIE icon
2162
Erie Indemnity
ERIE
$13.4B
$73K ﹤0.01%
314
-774
-71% -$185K
ESE icon
2163
ESCO Technologies
ESE
$7.71B
$73K ﹤0.01%
762
+75
+11% +$6.96K
GPRO icon
2164
GoPro
GPRO
$118M
$73K ﹤0.01%
14,536
+8,133
+127% +$43.9K
HL icon
2165
Hecla Mining
HL
$11.9B
$73K ﹤0.01%
11,595
+7,412
+177% +$42.5K
KLIC icon
2166
Kulicke & Soffa
KLIC
$5.04B
$73K ﹤0.01%
1,385
-3,558
-72% -$185K
SAFT icon
2167
Safety Insurance
SAFT
$1.52B
$73K ﹤0.01%
976
+933
+2,170% +$76K
SENS icon
2168
Senseonics Holdings Inc
SENS
$411M
$73K ﹤0.01%
5,127
-720
-12% -$14.5K
BLU
2169
DELISTED
BELLUS Health Inc.
BLU
$73K ﹤0.01%
10,223
-490
-5% -$3.8K
BBIO icon
2170
BridgeBio Pharma
BBIO
$15.8B
$72K ﹤0.01%
4,388
-2,096
-32% -$24.4K
EPR icon
2171
EPR Properties
EPR
$4.75B
$72K ﹤0.01%
1,883
+341
+22% +$13.6K
FBNC icon
2172
First Bancorp
FBNC
$2.73B
$72K ﹤0.01%
2,044
+1,777
+666% +$70.7K
FXL icon
2173
First Trust Technology AlphaDEX Fund
FXL
$2.89B
$72K ﹤0.01%
682
+94
+16% +$9.48K
IEV icon
2174
iShares Europe ETF
IEV
$1.7B
$72K ﹤0.01%
1,429
+157
+12% +$7.67K
IYK icon
2175
iShares US Consumer Staples ETF
IYK
$1.43B
$72K ﹤0.01%
1,071
+945
+750% +$61.8K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.